Prolonged colonization of mice by Vibrio cholerae El Tor O1 depends on accessory toxins.
Cholera epidemics caused by Vibrio cholerae El Tor O1 strains are typified by a large number of asymptomatic carriers who excrete vibrios but do not develop diarrhea. This carriage state was important for the spread of the seventh cholera pandemic as the bacterium was mobilized geographically, allowing the global dispersion of this less virulent strain. Virulence factors associated with the development of the carriage state have not been previously identified. We have developed an animal model of cholera in adult C57BL/6 mice wherein V. cholerae colonizes the mucus layer and forms microcolonies in the crypts of the distal small bowel. Colonization occurred 1 to 3 h after oral inoculation and peaked at 10 to 12 h, when bacterial loads exceeded the inoculum by 10- to 200-fold, indicating bacterial growth within the small intestine. After a clearance phase, the number of bacteria within the small intestine, but not those in the cecum or colon, stabilized and persisted for at least 72 h. The ability of V. cholerae to prevent clearance and establish this prolonged colonization was associated with the accessory toxins hemolysin, the multifunctional autoprocessing RTX toxin, and hemagglutinin/protease and did not require cholera toxin or toxin-coregulated pili. The defect in colonization attributed to the loss of the accessory toxins may be extracellularly complemented by inoculation of the defective strain with an isogenic colonization-proficient V. cholerae strain. This work thus demonstrates that secreted accessory toxins modify the host environment to enable prolonged colonization of the small intestine in the absence of overt disease symptoms and thereby contribute to disease dissemination via asymptomatic carriers.
Olivier
Verena
V
Department of Microbiology-Immunology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.
Salzman
Nita H
NH
Satchell
Karla J Fullner
KJ
D000818:Animals; D001426:Bacterial Proteins / Q000235:genetics / Q000633:toxicity; D001427:Bacterial Toxins / Q000235:genetics / Q000633:toxicity*; D002353:Carrier State / Q000382:microbiology*; D002771:Cholera / Q000382:microbiology; D002772:Cholera Toxin / Q000235:genetics / Q000633:toxicity; D015169:Colony Count, Microbial; D005260:Female; D010861:Fimbriae, Bacterial; D006460:Hemolysin Proteins / Q000235:genetics / Q000633:toxicity; D007422:Intestines / Q000382:microbiology; D008666:Metalloendopeptidases / Q000235:genetics / Q000633:toxicity; D051379:Mice; D008810:Mice, Inbred C57BL; D041241:Vibrio cholerae O1 / Q000254:growth & development* / Q000472:pathogenicity; D037521:Virulence Factors / Q000235:genetics / Q000502:physiology*
D001426:Bacterial Proteins; D001427:Bacterial Toxins; D006460:Hemolysin Proteins; C434464:RtxA protein, Vibrio cholerae; D037521:Virulence Factors; C084287:hlyA protein, Vibrio cholerae; D002772:Cholera Toxin; D008666:Metalloendopeptidases; C039814:hemagglutinin-protease
J Trop Med Hyg. 1980 Feb;83(1):35-9
7365863
Infect Immun. 2000 Jan;68(1):221-6
10603391
Microbes Infect. 2003 Nov;5(13):1241-7
14623020
Eur J Clin Microbiol Infect Dis. 2000 Jun;19(6):489-91
10947231
Infect Immun. 2001 Mar;69(3):1528-35
11179323
FEMS Microbiol Lett. 1993 Jul 15;111(1):15-21
8359676
J Infect Dis. 1994 Dec;170(6):1518-23
7995992
Am J Trop Med Hyg. 1997 May;56(5):533-7
9180604
Clin Infect Dis. 1993 Mar;16 Suppl 2:S83-91
8452965
EMBO J. 2000 Oct 16;19(20):5315-23
11032799
Mol Microbiol. 2000 Feb;35(4):896-910
10692166
PLoS Pathog. 2006 Jan;2(1):e3
16446782
Diagn Microbiol Infect Dis. 2004 Aug;49(4):295-7
15313536
Am J Epidemiol. 1972 Nov;96(5):342-51
4564735
Infect Immun. 2005 Sep;73(9):6157-64
16113340
Infect Immun. 2007 Oct;75(10):5035-42
17698573
J Infect Dis. 1986 Jul;154(1):183-6
3519790
J Infect Dis. 2003 Jan 1;187(1):96-101
12508151
Am J Physiol. 1997 Jan;272(1 Pt 1):G197-206
9038894
Nature. 1983 Dec 8-14;306(5943):551-7
6646234
Bull World Health Organ. 1993;71(2):189-96
8490982
J Infect Dis. 1993 Dec;168(6):1536-40
8245542
Immunol Today. 1999 Feb;20(2):95-101
10098329
Proc Natl Acad Sci U S A. 1987 May;84(9):2833-7
2883655
Clin Microbiol Rev. 1995 Jan;8(1):48-86
7704895
Rev Infect Dis. 1989 May-Jun;11 Suppl 3:S568-73
2669100
Cell Microbiol. 2007 May;9(5):1324-35
17474905
Annu Rev Microbiol. 1980;34:341-67
7002028
Lancet. 1988 Aug 27;2(8609):467-70
2900401
Infect Immun. 1988 Dec;56(12):3241-50
2903129
Trends Microbiol. 2000 Apr;8(4):189-91
10754579
Am J Physiol. 1995 May;268(5 Pt 1):G813-22
7762665
J Exp Med. 1997 Apr 7;185(7):1203-10
9104807
Infect Immun. 1999 Aug;67(8):3733-9
10417131
Lancet. 1995 Apr 15;345(8955):949-52
7715293
J Bacteriol. 1986 Mar;165(3):715-22
3005236
Proc Natl Acad Sci U S A. 1999 Feb 2;96(3):1071-6
9927695
Methods Mol Biol. 2006;341:17-35
16799186
Infect Immun. 1996 Jul;64(7):2853-6
8698524
Infect Immun. 1988 Jun;56(6):1414-9
2453464
Infect Immun. 1988 Oct;56(10):2753-9
3417355
J Infect Dis. 1970 May;121:Suppl 121:17+
4912068
Microbiol Immunol. 1998;42(1):41-5
9525778
Mol Microbiol. 1999 Nov;34(4):836-49
10564522
Lancet. 1966 Feb 12;1(7433):340-2
4159477
Aust J Exp Biol Med Sci. 1975 Apr;53(2):137-46
1164261
J Infect Dis. 1995 Sep;172(3):883-6
7658089
Indian J Med Res. 1979 Dec;70:892-7
541013
J Exp Med. 2002 Jun 3;195(11):1455-62
12045243
Infect Immun. 1996 Jun;64(6):2362-4
8675353
Infect Immun. 1999 Mar;67(3):1393-404
10024587
Lancet. 2004 Jan 17;363(9404):223-33
14738797